Durvalumab vs Levothyroxine

Durvalumab vs Levothyroxine: Overview

This comparison examines the pharmacological differences between Durvalumab and Levothyroxine.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Levothyroxine: Synthetic thyroid hormone T4 replacement.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Levothyroxine — 6-7 days.

Chemical Properties

Molecular Formula: Levothyroxine — C15H11I4NO4.

Molecular Weight: Levothyroxine — 776.8700 g/mol.

Type: Durvalumab — Antibody; Levothyroxine — Small molecule.